TINAVI MEDICAL TECHNOLOGIES CO.,LTD. Financials Tinavi Medical Technologies Co.,Ltd.
Equities
688277
CNE100004256
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.85 CNY | -3.17% |
|
-1.23% | -32.85% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 15,955 | 11,021 | 4,992 | 5,923 |
| Enterprise Value (EV) 1 | 15,235 | 10,684 | 4,839 | 5,782 |
| P/E ratio | -272 x | -138 x | -45.7 x | -37.7 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 117 x | 70.6 x | 32 x | 28.2 x |
| EV / Revenue | 112 x | 68.5 x | 31 x | 27.5 x |
| EV / EBITDA | -163 x | -80.9 x | -30.3 x | -33.3 x |
| EV / FCF | -91 x | -33.8 x | -43.5 x | -18.1 x |
| FCF Yield | -1.1% | -2.95% | -2.3% | -5.52% |
| Price to Book | 16 x | 10.9 x | 4.78 x | 4.79 x |
| Nbr of stocks (in thousands) | 418,443 | 419,847 | 419,847 | 449,392 |
| Reference price 2 | 38.13 | 26.25 | 11.89 | 13.18 |
| Announcement Date | 4/9/21 | 4/25/22 | 4/25/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 126.7 | 229.6 | 135.9 | 156 | 156.2 | 210 |
| EBITDA 1 | -30.69 | -53.82 | -93.46 | -132 | -159.5 | -173.8 |
| EBIT 1 | -36.41 | -66.72 | -100.6 | -140.9 | -174.9 | -197.8 |
| Operating Margin | -28.73% | -29.06% | -73.99% | -90.28% | -111.96% | -94.17% |
| Earnings before Tax (EBT) 1 | -7.992 | -42.84 | -68.4 | -104.7 | -144.2 | -150.7 |
| Net income 1 | -0.856 | -30.96 | -54.47 | -79.93 | -110.6 | -156.4 |
| Net margin | -0.68% | -13.49% | -40.08% | -51.23% | -70.8% | -74.46% |
| EPS | - | -0.0800 | -0.1400 | -0.1900 | -0.2600 | -0.3500 |
| Free Cash Flow 1 | -431.4 | -12.09 | -167.5 | -315.7 | -111.4 | -319 |
| FCF margin | -340.45% | -5.26% | -123.21% | -202.32% | -71.3% | -151.87% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 6/30/20 | 6/30/20 | 4/9/21 | 4/25/22 | 4/25/23 | 4/25/24 |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 461 | 425 | 721 | 337 | 153 | 141 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -431 | -12.1 | -167 | -316 | -111 | -319 |
| ROE (net income / shareholders' equity) | -1% | -5.91% | -6.68% | -7.89% | -10.3% | -13.7% |
| ROA (Net income/ Total Assets) | -3.54% | -6.06% | -6.86% | -7.34% | -8.14% | -8.17% |
| Assets 1 | 24.17 | 510.9 | 794.2 | 1,089 | 1,359 | 1,914 |
| Book Value Per Share | - | 1.550 | 2.380 | 2.400 | 2.490 | 2.750 |
| Cash Flow per Share | - | 0.4100 | 1.120 | 0.6800 | 0.5000 | 0.6900 |
| Capex 1 | 27.4 | 20.2 | 132 | 239 | 59.6 | 221 |
| Capex / Sales | 21.59% | 8.79% | 97.25% | 152.97% | 38.15% | 105.23% |
| Announcement Date | 6/30/20 | 6/30/20 | 4/9/21 | 4/25/22 | 4/25/23 | 4/25/24 |
1CNY in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -32.85% | 550M | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +13.73% | 52.26B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B |
- Stock Market
- Equities
- 688277 Stock
- Financials Tinavi Medical Technologies Co.,Ltd.